Ascendis Pharma A/S (ASND)
USD 163.34
(3.28%)
USD 163.34
(3.28%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 222.32 Million EUR | 469.52% |
| 2022 | 39.03 Million EUR | 817.44% |
| 2021 | 4.25 Million EUR | -38.8% |
| 2020 | 6.95 Million EUR | -48.01% |
| 2019 | 13.37 Million EUR | 26.41% |
| 2018 | 10.58 Million EUR | 591.57% |
| 2017 | 1.53 Million EUR | -66.78% |
| 2016 | 4.6 Million EUR | -43.26% |
| 2015 | 8.11 Million EUR | -41.94% |
| 2014 | 13.98 Million EUR | -31.48% |
| 2013 | 20.4 Million EUR | 30.96% |
| 2012 | 15.58 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 88.32 Million EUR | -25.3% |
| 2024 Q2 | 22.66 Million EUR | -72.22% |
| 2023 Q4 | 118.24 Million EUR | 190.91% |
| 2023 FY | 222.32 Million EUR | 469.52% |
| 2023 Q1 | 28.96 Million EUR | 62.89% |
| 2023 Q2 | 34.46 Million EUR | 18.97% |
| 2023 Q3 | 40.64 Million EUR | 17.94% |
| 2022 Q4 | 17.78 Million EUR | 30.79% |
| 2022 Q3 | 13.59 Million EUR | 167.97% |
| 2022 Q1 | 2.58 Million EUR | 187.71% |
| 2022 Q2 | 5.07 Million EUR | 96.51% |
| 2022 FY | 39.03 Million EUR | 817.44% |
| 2021 Q3 | 1.11 Million EUR | 8.9% |
| 2021 FY | 4.25 Million EUR | -38.8% |
| 2021 Q2 | 1.02 Million EUR | 37.0% |
| 2021 Q1 | 746 Thousand EUR | 100.4% |
| 2021 Q4 | -2.94 Million EUR | -364.49% |
| 2020 Q3 | -61.3 Million EUR | 1.35% |
| 2020 Q4 | -184.61 Million EUR | -201.16% |
| 2020 FY | 6.95 Million EUR | -48.01% |
| 2020 Q2 | -62.14 Million EUR | -12.39% |
| 2020 Q1 | -55.29 Million EUR | -2305.42% |
| 2019 Q1 | 5.41 Million EUR | -48.51% |
| 2019 FY | 13.37 Million EUR | 26.41% |
| 2019 Q4 | 2.5 Million EUR | 11.77% |
| 2019 Q3 | 2.24 Million EUR | 105.52% |
| 2019 Q2 | -40.61 Million EUR | -850.18% |
| 2018 FY | 10.58 Million EUR | 591.57% |
| 2018 Q4 | 10.51 Million EUR | 52475.0% |
| 2018 Q2 | 18 Thousand EUR | -35.71% |
| 2018 Q1 | 28 Thousand EUR | -90.0% |
| 2018 Q3 | 20 Thousand EUR | 11.11% |
| 2017 Q3 | 434 Thousand EUR | -2.25% |
| 2017 FY | 1.53 Million EUR | -66.78% |
| 2017 Q1 | 372 Thousand EUR | -64.33% |
| 2017 Q2 | 444 Thousand EUR | 19.35% |
| 2017 Q4 | 280 Thousand EUR | -35.48% |
| 2016 Q4 | 1.04 Million EUR | -10.78% |
| 2016 FY | 4.6 Million EUR | -43.26% |
| 2016 Q1 | 1.25 Million EUR | -36.37% |
| 2016 Q3 | 1.16 Million EUR | 2.9% |
| 2016 Q2 | 1.13 Million EUR | -9.7% |
| 2015 Q1 | 2.08 Million EUR | -26.36% |
| 2015 Q4 | 1.97 Million EUR | -6.61% |
| 2015 Q3 | 2.11 Million EUR | 8.96% |
| 2015 Q2 | 1.94 Million EUR | -6.63% |
| 2015 FY | 8.11 Million EUR | -41.94% |
| 2014 Q1 | 3.99 Million EUR | -28.15% |
| 2014 Q3 | 3.25 Million EUR | -16.94% |
| 2014 Q2 | 3.91 Million EUR | -2.03% |
| 2014 FY | 13.98 Million EUR | -31.48% |
| 2014 Q4 | 2.82 Million EUR | -13.05% |
| 2013 Q3 | 6.06 Million EUR | 38.21% |
| 2013 Q1 | 4.39 Million EUR | 0.0% |
| 2013 FY | 20.4 Million EUR | 30.96% |
| 2013 Q4 | 5.55 Million EUR | -8.39% |
| 2013 Q2 | 4.39 Million EUR | 0.0% |
| 2012 FY | 15.58 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Agenus Inc. | 139.61 Million USD | -59.24% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 42286.528% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -663.236% |
| Acelyrin, Inc. | -115 Thousand USD | 193424.348% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -64.356% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -4978.186% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -44723.185% |
| IO Biotech, Inc. | -756 Thousand USD | 29507.804% |
| Ardelyx, Inc. | 106.66 Million USD | -108.439% |
| Geron Corporation | -123.5 Million USD | 280.014% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -1241.153% |
| Innoviva, Inc. | 261.06 Million USD | 14.84% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 404323.636% |
| ChromaDex Corporation | 50.78 Million USD | -337.816% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -85.651% |
| Onconetix, Inc. | -1.12 Million USD | 19824.087% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 867.478% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 155244.067% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 309.496% |
| Vaxcyte, Inc. | -75 Million USD | 396.431% |
| Pharming Group N.V. | 220.1 Million USD | -1.008% |
| ContextLogic Inc. | 59 Million USD | -276.819% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 95928.879% |
| Pyxis Oncology, Inc. | -2 Million USD | 11216.15% |
| AlloVir, Inc. | -398 Thousand USD | 55960.05% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -665.18% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 2212049.06% |
| Summit Therapeutics Inc. | -2.05 Million USD | 10945.024% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 39035.727% |
| Senti Biosciences, Inc. | -2.68 Million USD | 8386.359% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 4733.66% |
| Psyence Biomedical Ltd. | -240.00 USD | 92634683.333% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 503229.809% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 387922.28% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 271225.61% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -113.569% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -43069.515% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -21933.994% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 6121.75% |
| Elevation Oncology, Inc. | -39 Thousand USD | 570158.974% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -84.54% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 5739.784% |
| AbCellera Biologics Inc. | 38.02 Million USD | -484.676% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 43123.652% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 590.509% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -27621.072% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -931.901% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 187728.596% |
| Vaxxinity, Inc. | -2.23 Million USD | 10051.791% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 1111.157% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 23522.787% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 4446560.0% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -5388.102% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 127255.791% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -52334.67% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -1067.479% |
| Opthea Limited | 21.72 Thousand USD | -1023486.556% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 222.554% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 326.359% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 1070.038% |
| Molecular Templates, Inc. | 50.39 Million USD | -341.161% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -656.535% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 45287.602% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -36406.24% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -8537.257% |
| ADMA Biologics, Inc. | 88.21 Million USD | -152.015% |
| Alkermes plc | 1.37 Billion USD | 83.827% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 85.353% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 438261.214% |
| AnaptysBio, Inc. | 14.78 Million USD | -1404.113% |
| Aptorum Group Limited | -1.11 Million USD | 20044.863% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 7.648% |
| Bicycle Therapeutics plc | -129.52 Million USD | 271.651% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -185169.167% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 329.317% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -2724.584% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 11863.122% |
| Chimerix, Inc. | 324 Thousand USD | -68518.21% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 29.122% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 813.313% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 386.506% |
| CRISPR Therapeutics AG | 240.95 Million USD | 7.733% |
| Precision BioSciences, Inc. | 40.47 Million USD | -449.325% |
| Dyadic International, Inc. | 922.95 Thousand USD | -23988.121% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -955.615% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 326.484% |
| Fortress Biotech, Inc. | 57.85 Million USD | -284.289% |
| Fortress Biotech, Inc. | 57.85 Million USD | -284.289% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| ImmuCell Corporation | 4.39 Million USD | -4957.066% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1764.362% |
| Immix Biopharma, Inc. | -5468.00 USD | 4065992.465% |
| Incyte Corporation | 3.44 Billion USD | 93.538% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 151340.136% |
| Jaguar Health, Inc. | 7.72 Million USD | -2778.34% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 574.654% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 33582.38% |
| MiMedx Group, Inc. | 266.84 Million USD | 16.684% |
| MEI Pharma, Inc. | 49.32 Million USD | -350.713% |
| Mesoblast Limited | -9.81 Million USD | 2365.135% |
| Novavax, Inc. | 639.93 Million USD | 65.259% |
| NextCure, Inc. | -3.68 Million USD | 6134.826% |
| Precigen, Inc. | 106 Thousand USD | -209638.679% |
| PureTech Health plc | -1.6 Million USD | 13969.183% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -102.532% |
| Seer, Inc. | 7.02 Million USD | -3063.839% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 1852791.667% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 3232.192% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 46949.719% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 2137821.154% |
| Soligenix, Inc. | 97.31 Thousand USD | -228366.463% |
| Century Therapeutics, Inc. | -10.8 Million USD | 2156.832% |
| Kura Oncology, Inc. | -849 Thousand USD | 26286.455% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 431.311% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -124.48% |
| Autolus Therapeutics plc | -4.86 Million USD | 4667.968% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -437.194% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 132435.119% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -134.709% |
| GRI Bio, Inc. | 10.84 Million USD | -1950.761% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -8652.922% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 2659.261% |
| IGM Biosciences, Inc. | -211.66 Million USD | 205.038% |
| INmune Bio, Inc. | 155 Thousand USD | -143334.194% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -258.939% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 14859.631% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 34385.084% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 759555.49% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -55204.229% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 11238.427% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 71129.712% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -135.36% |
| Verastem, Inc. | -62 Thousand USD | 358685.484% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -9030.308% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 85281.226% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -7244.665% |
| Histogen Inc. | 3.76 Million USD | -5798.726% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -38485.752% |
| Surrozen, Inc. | -27.23 Million USD | 916.463% |
| Organovo Holdings, Inc. | -5.38 Million USD | 4225.496% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 18551.879% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 966.858% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -1008.732% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 11228534.343% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -3564.812% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 331277.846% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -43.628% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -152384.911% |
| Apollomics, Inc. | 127 Thousand USD | -174957.48% |
| Amarin Corporation plc | 165.54 Million USD | -34.301% |
| Turnstone Biologics Corp. | 16.5 Million USD | -1246.922% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 301.217% |
| Synaptogenix, Inc. | -6347.00 USD | 3502904.475% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 436027.451% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -37.776% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 87.351% |
| Better Therapeutics, Inc. | -2.72 Million USD | 8246.684% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 298.218% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 34.24% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1948934.151% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 3651.486% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 20165.253% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -2938.029% |
| Insmed Incorporated | 239.63 Million USD | 7.224% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -6113.611% |
| OmniAb, Inc. | 14.66 Million USD | -1415.804% |
| Alector, Inc. | -95.05 Million USD | 333.894% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -76.979% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 611.522% |
| Zai Lab Limited | 170.9 Million USD | -30.087% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -171.533% |
| Aura Biosciences, Inc. | -1.29 Million USD | 17267.799% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -170917.692% |
| Immunic, Inc. | -111 Thousand USD | 200390.991% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -1302.315% |
| Veracyte, Inc. | 248.14 Million USD | 10.407% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 103.181% |
| FibroGen, Inc. | 128.9 Million USD | -72.472% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 39419071.631% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 2005.59% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 93.458% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -57052.442% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 37.435% |
| TG Therapeutics, Inc. | 219.1 Million USD | -1.467% |
| Galecto, Inc. | -830 Thousand USD | 26885.904% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 16152.202% |
| Fortrea Holdings Inc. | 424 Million USD | 47.565% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 358.014% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 39310.406% |
| XBiotech Inc. | -1.74 Million USD | 12847.878% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 20165.253% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 578.412% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 394.335% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -202.88% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -1223.115% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 42.853% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 547.808% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 31.96% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 2063.318% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -809.259% |
| NexImmune, Inc. | -1.02 Million USD | 21790.641% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -4116992.593% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 3228.817% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 98.033% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 332784.394% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 6360.856% |
| Ainos, Inc. | -253.73 Thousand USD | 87720.846% |
| Pluri Inc. | 322 Thousand USD | -68944.41% |
| Prothena Corporation plc | -129.2 Million USD | 272.075% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -340.908% |
| Celularity Inc. | 6.75 Million USD | -3191.236% |
| Rallybio Corporation | -150 Thousand USD | 148315.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | 781.826% |
| MeiraGTx Holdings plc | 287 Thousand USD | -77364.46% |
| Omeros Corporation | -69.77 Million USD | 418.61% |
| Humacyte, Inc. | -76.55 Million USD | 390.428% |
| Immunocore Holdings plc | 248.39 Million USD | 10.495% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1565.64% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -256.39% |
| Blueprint Medicines Corporation | 236.58 Million USD | 6.028% |
| CalciMedica, Inc. | -58 Thousand USD | 383415.517% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 15690.673% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 7917.264% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 820.308% |
| Pulmatrix, Inc. | -8.22 Million USD | 2804.659% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 19101.966% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 55820.05% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 155.749% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -7909.951% |
| Cytokinetics, Incorporated | -322.59 Million USD | 168.917% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -25688.39% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 65297.361% |
| Vor Biopharma Inc. | -3.49 Million USD | 6466.638% |
| Roivant Sciences Ltd. | 109.23 Million USD | -103.527% |
| Evogene Ltd. | 1.39 Million USD | -15791.565% |
| ProKidney Corp. | -3.16 Million USD | 7115.557% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 606.292% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -3142.278% |
| CorMedix Inc. | -205.56 Thousand USD | 108253.744% |
| BioLineRx Ltd. | 1.1 Million USD | -19965.253% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 382.598% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 673806.061% |
| Atai Life Sciences N.V. | -5000.00 USD | 4446560.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 182542.823% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 231686.458% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 16105.976% |
| Sagimet Biosciences Inc. | 2 Million USD | -11016.15% |
| MediciNova, Inc. | 979.7 Thousand USD | -22592.851% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 363.669% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 235225.588% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1172.948% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 9.083% |
| Biomea Fusion, Inc. | -4.2 Million USD | 5392.145% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 74.514% |
| Mereo BioPharma Group plc | 7.42 Million USD | -2893.846% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 71817.097% |
| Absci Corporation | -41.84 Million USD | 631.25% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4446560.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 391.102% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 9133.848% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -4.018% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 23726.249% |
| Allakos Inc. | -6.14 Million USD | 3720.306% |
| Imunon, Inc. | -720 Thousand USD | 30977.98% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 422.226% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 53.283% |
| BioAtla, Inc. | -103.73 Million USD | 314.326% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1948934.151% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 125000.562% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 191.559% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 71586.495% |
| XOMA Corporation | 3.86 Million USD | -5658.171% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 417.219% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -1402.792% |
| aTyr Pharma, Inc. | -2.38 Million USD | 9410.008% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -1684.294% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 766731.034% |
| Viridian Therapeutics, Inc. | -1 Million USD | 22155.853% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1710176823.077% |
| Akari Therapeutics, Plc | -4000.00 USD | 5558175.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 65.093% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -114082.776% |
| UroGen Pharma Ltd. | 73.35 Million USD | -203.091% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 932.858% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -1914826.787% |
| Orgenesis Inc. | -5.72 Million USD | 3983.371% |
| Entera Bio Ltd. | -56 Thousand USD | 397105.357% |
| GH Research PLC | -315 Thousand USD | 70678.73% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 117731.217% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 42447.238% |
| Xencor, Inc. | -85.26 Million USD | 360.759% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 100709.113% |
| Replimune Group, Inc. | -2.65 Million USD | 8473.748% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 22304.855% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -25.01% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -114082.776% |
| Portage Biotech Inc. | -54 Thousand USD | 411809.259% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 235225.588% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 59071.618% |
| OncoCyte Corporation | 413 Thousand USD | -53731.235% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 4946106.674% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 100145595.495% |
| Purple Biotech Ltd. | -196 Thousand USD | 113530.102% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -2379.07% |
| scPharmaceuticals Inc. | 9.78 Million USD | -2172.777% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 2228.52% |
| HilleVax, Inc. | -2.15 Million USD | 10411.827% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 229298.969% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 1481858.198% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 33381.886% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 966721.739% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 2961973.981% |
| Savara Inc. | -44.26 Million USD | 602.289% |
| Curis, Inc. | 9.81 Million USD | -2166.059% |
| Daré Bioscience, Inc. | 2.76 Million USD | -7927.486% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 178260.56% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 12958.473% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 97610.088% |
| BeiGene, Ltd. | 2.07 Billion USD | 89.306% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 8051.751% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 155.627% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -292.187% |
| Erasca, Inc. | -3.73 Million USD | 6057.208% |
| bluebird bio, Inc. | -4.03 Million USD | 5616.7% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 787976.533% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 88.326% |
| DBV Technologies S.A. | 15.72 Million USD | -1313.549% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 787976.533% |
| Moderna, Inc. | 2.15 Billion USD | 89.683% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 24397.596% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -2676.955% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 41578.172% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -66.176% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 3673.176% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 665.089% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 300.06% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 6296.293% |
| MacroGenics, Inc. | 50.52 Million USD | -340.008% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 3745.835% |
| Prime Medicine, Inc. | -147.9 Million USD | 250.315% |
| Aditxt, Inc. | -111.66 Thousand USD | 199207.111% |
| Adagene Inc. | 18.11 Million USD | -1127.525% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -45457.992% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -58.573% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -40.857% |
| SciSparc Ltd. | 2.19 Million USD | -10023.998% |
| Vericel Corporation | 135.57 Million USD | -63.984% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 887652.397% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 717687.632% |
| Generation Bio Co. | -73.91 Million USD | 400.798% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 50974.828% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -307.043% |
| Invivyd, Inc. | -2.02 Million USD | 11062.673% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 173.9% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 215033.583% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -130.702% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -126.195% |
| Clene Inc. | 533 Thousand USD | -41611.632% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -822.151% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 23331.243% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1172.948% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -11083.249% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 114513.121% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -346.387% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 3234.842% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 26693.66% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -166.526% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -303985.513% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -318.199% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 228.371% |
| Trevena, Inc. | 1.45 Million USD | -15179.931% |
| Surrozen, Inc. | -27.23 Million USD | 916.463% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 63081.02% |
| Cingulate Inc. | -582.91 Thousand USD | 38239.67% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 717270.968% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 1228.6% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 2936995.641% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 25335.301% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 67.339% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 22602.328% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 394695.506% |
| Kronos Bio, Inc. | 1.37 Million USD | -16104.3% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 514.272% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 76238.014% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 45628.697% |
| ImmunityBio, Inc. | -17.89 Million USD | 1342.722% |
| Korro Bio, Inc. | -3.63 Million USD | 6224.601% |
| Kineta, Inc. | 5.43 Million USD | -3992.085% |
| BioVie Inc. | -229.37 Thousand USD | 97024.713% |
| Codexis, Inc. | 57.33 Million USD | -287.768% |
| Celularity Inc. | 6.75 Million USD | -3191.236% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -5440.07% |
| Celcuity Inc. | -142.77 Thousand USD | 155818.908% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -439360.368% |
| Cibus, Inc. | 1.42 Million USD | -15534.529% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 59544.652% |
| IN8bio, Inc. | -2.5 Million USD | 8989.364% |
| Kodiak Sciences Inc. | -25.94 Million USD | 956.835% |
| Annexon, Inc. | -3.26 Million USD | 6905.112% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 10976.859% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 632.676% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -34637.969% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 71.443% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -28.544% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 11801.211% |
| Arcellx, Inc. | 108.27 Million USD | -105.324% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 786.839% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -180.697% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 1151.073% |
| Moolec Science SA | -143.3 Thousand USD | 155239.737% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 625.363% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -6663.706% |
| Royalty Pharma plc | 1.79 Billion USD | 87.607% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 417.196% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 6155221.816% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -95981.092% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 299.547% |
| Humacyte, Inc. | -76.55 Million USD | 390.428% |
| 89bio, Inc. | -273 Thousand USD | 81536.996% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 17786.794% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 26317.335% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 180850.407% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -19768.007% |
| Notable Labs, Ltd. | 113 Thousand USD | -196646.018% |
| Liquidia Corporation | 14.6 Million USD | -1422.76% |
| Mustang Bio, Inc. | -2.22 Million USD | 10092.045% |
| Immunovant, Inc. | -231 Thousand USD | 96343.723% |
| Quantum-Si incorporated | 488 Thousand USD | -45457.992% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 500.157% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 741176.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -11840.011% |
| Acasti Pharma Inc. | -11 Thousand USD | 2021218.182% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 108753.24% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 34385.084% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 232.721% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -19495.181% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 58452.493% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 11454.597% |
| PepGen Inc. | -1.18 Million USD | 18877.28% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 175157.48% |
| United Therapeutics Corporation | 2.07 Billion USD | 89.26% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 1070.97% |
| Solid Biosciences Inc. | -76.56 Million USD | 390.379% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 269311.581% |
| Immuneering Corporation | -764.13 Thousand USD | 29194.614% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -335410.986% |
| Belite Bio, Inc | -399 Thousand USD | 55820.05% |
| XOMA Corporation | 3.86 Million USD | -5658.171% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 1209.618% |
| Bionomics Limited | -434.44 Thousand USD | 51273.555% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 20800.466% |
| uniQure N.V. | 2.21 Million USD | -9937.156% |
| Cassava Sciences, Inc. | -89.42 Million USD | 348.619% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 341.474% |
| Forte Biosciences, Inc. | -9000.00 USD | 2470355.556% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 26725.509% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 50974.828% |
| Altimmune, Inc. | -65.37 Million USD | 440.084% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 38.59% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 20800.466% |
| Compugen Ltd. | 31.45 Million USD | -606.797% |
| Peak Bio, Inc. | 367.76 Thousand USD | -60351.805% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -806.849% |
| Benitec Biopharma Inc. | 108 Thousand USD | -205754.63% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 285129.487% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 18580.715% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 12302.141% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 186926.05% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 18580.715% |
| Instil Bio, Inc. | -4.75 Million USD | 4774.579% |
| argenx SE | 1.1 Billion USD | 79.943% |
| Immunome, Inc. | -8.9 Million USD | 2596.048% |
| Verona Pharma plc | -679.62 Thousand USD | 32812.647% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 127141.714% |
| Shattuck Labs, Inc. | -2.38 Million USD | 9421.719% |
| CervoMed Inc. | -1.29 Million USD | 17286.02% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 9336.518% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 4754.03% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -8897.289% |
| Moolec Science SA | -143.3 Thousand USD | 155239.737% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 54586.925% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 8421.942% |
| Design Therapeutics, Inc. | -537 Thousand USD | 41500.931% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 52166.276% |
| NeurAxis, Inc. | 2.15 Million USD | -10208.461% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -10259.879% |
| Lumos Pharma, Inc. | 2 Million USD | -10977.379% |
| Achilles Therapeutics plc | -4.73 Million USD | 4799.016% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 127141.714% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 210483.724% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -602.248% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -25688.39% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 21642.926% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 588.107% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -516930.233% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 27146.594% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1689741.283% |
| Palisade Bio, Inc. | 246 Thousand USD | -90275.203% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 673806.061% |
| Beam Therapeutics Inc. | -59.67 Million USD | 472.575% |
| Neurogene Inc. | -3.26 Million USD | 6915.543% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -59.56% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -455.808% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 74956.229% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 5620.759% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 2424.096% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -1478.999% |
| Athira Pharma, Inc. | -969 Thousand USD | 23043.55% |
| Vaccinex, Inc. | -16 Million USD | 1489.171% |
| HCW Biologics Inc. | -574.82 Thousand USD | 38776.708% |
| XOMA Corporation | 3.86 Million USD | -5658.171% |
| Nektar Therapeutics | 53.47 Million USD | -315.728% |
| Arvinas, Inc. | 71.8 Million USD | -209.642% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 366.379% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 454.159% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 69144.41% |
| Rezolute, Inc. | -36 Thousand USD | 617663.889% |
| Clene Inc. | 533 Thousand USD | -41611.632% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 17314975.389% |
| BeyondSpring Inc. | 1.75 Million USD | -12596.916% |
| Synlogic, Inc. | -1.92 Million USD | 11655.249% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 600972.973% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 3611.102% |
| Peak Bio, Inc. | 367.76 Thousand USD | -60351.805% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 1272.404% |
| Krystal Biotech, Inc. | 47.6 Million USD | -367.016% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -57.574% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -4324.338% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 8686.489% |
| MannKind Corporation | 136.19 Million USD | -63.244% |
| Ikena Oncology, Inc. | -50.49 Million USD | 540.313% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -104.315% |
| Gossamer Bio, Inc. | -4.38 Million USD | 5170.08% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 88323.413% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4446560.0% |
| Legend Biotech Corporation | 140.92 Million USD | -57.755% |
| Mural Oncology plc | -2.56 Million USD | 8760.81% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 40449.002% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 222423.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -971.23% |
| REGENXBIO Inc. | 53.02 Million USD | -319.248% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 4250.176% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 115667.511% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 12936.201% |
| Vaxart, Inc. | -60.76 Million USD | 465.885% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 84704.232% |
| Cellectis S.A. | 18 Thousand USD | -1235027.778% |
| Longeveron Inc. | 221 Thousand USD | -100498.643% |
| Repare Therapeutics Inc. | -80.07 Million USD | 377.661% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 79.659% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 17281.066% |
| Revolution Medicines, Inc. | -399.66 Million USD | 155.627% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 635308.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -453620.408% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 97.417% |
| Denali Therapeutics Inc. | -93.34 Million USD | 338.173% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 887652.397% |
| Veru Inc. | 7.56 Million USD | -2838.476% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 147333.775% |
| Cingulate Inc. | -582.91 Thousand USD | 38239.67% |
| Passage Bio, Inc. | -3.72 Million USD | 6074.819% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 1846023.281% |
| Exicure, Inc. | -1.42 Million USD | 15723.542% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 58147.781% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -8125.046% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 43465.29% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -226.341% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 148704.678% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 475.508% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -56760.102% |
| OmniAb, Inc. | 14.66 Million USD | -1415.804% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -1012.004% |
| Lipocine Inc. | -2.85 Million USD | 7898.569% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 12163.104% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 3996.985% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 14859.631% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -195.187% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 342135.385% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -163.741% |
| Ocugen, Inc. | -33.53 Million USD | 762.919% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 7131.088% |
| Q32 Bio Inc. | 578 Thousand USD | -38364.187% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 83995.472% |
| Alumis Inc. Common Stock | -1.28 Million USD | 17414.875% |
| Equillium, Inc. | 35.95 Million USD | -518.285% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 13124.194% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -44304.299% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 5378014.852% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 85938.996% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -52494.438% |
| Dominari Holdings Inc. | 2.03 Million USD | -10803.531% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 121276.099% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1735.329% |
| Bio-Techne Corporation | 773.07 Million USD | 71.242% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -1183.694% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 51.751% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 19118.221% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 1027.118% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -1800.684% |
| Nkarta, Inc. | -5.86 Million USD | 3888.09% |
| BioCardia, Inc. | -7.24 Million USD | 3166.947% |
| Iterum Therapeutics plc | -1.75 Million USD | 12804.171% |